Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
A retrospective chart study demonstrated the effectiveness of fosfomycin as an antibacterial prophylaxis for febrile neutropenia in patients with hematologic cancer.
A retrospective chart study demonstrated the effectiveness of fosfomycin as an antibacterial prophylaxis for febrile neutropenia in patients with hematologic cancer.
Targeted prophylaxis strategy is most cost-effective in highest risk men who have sex with men.
Web-based decision aid lowers decisional conflict, helps women decide about prophylactic treatment.
Phase II study shows Factor Xa inhibitor is safe and tolerated in chemotherapy-treated patients.
Semuloparin prophylaxis reduces the incidence of thromboembolic events during chemotherapy, with no increase in major bleeding.
Prophylactic antibiotics, barrier isolation and air quality control measures can substantially reduce the risk of death in high-risk cancer patients after chemotherapy, a systematic review has shown